| 13th May 2022 7:00 am |
RNS |
ONT chosen for comprehensive human genome program |
| 11th May 2022 4:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 3rd May 2022 4:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 12th Apr 2022 6:15 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 12th Apr 2022 1:01 pm |
RNS |
Director/PDMR Shareholding |
| 12th Apr 2022 1:01 pm |
RNS |
Director/PDMR Shareholding |
| 12th Apr 2022 1:00 pm |
RNS |
Director/PDMR Shareholding |
| 12th Apr 2022 7:00 am |
RNS |
Publication of Annual Report and Notice of AGM |
| 6th Apr 2022 1:00 pm |
RNS |
Block listing Interim Review |
| 5th Apr 2022 11:00 am |
RNS |
Director/PDMR Shareholding |
| 4th Apr 2022 2:00 pm |
RNS |
Genomics England expands Nanopore use in cancer |
| 1st Apr 2022 5:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 1st Apr 2022 7:00 am |
RNS |
Agreement |
| 30th Mar 2022 2:00 pm |
RNS |
ONT shows new high-accuracy, high-output chemistry |
| 24th Mar 2022 7:00 am |
RNS |
Nanopore sequencing profiles TB: FIND evaluation |
| 23rd Mar 2022 2:02 pm |
RNS |
Oxford Nanopore releases Short Fragment Mode |
| 22nd Mar 2022 7:00 am |
RNS |
Preliminary Results and Guidance Update |
| 11th Mar 2022 5:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 10th Mar 2022 12:30 pm |
RNS |
Holding(s) in Company |
| 8th Mar 2022 7:03 am |
RNS |
Publication: Nanopore IDs >50 genetic diseases |
| 1st Mar 2022 5:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 24th Feb 2022 7:00 am |
RNS |
Notice of Results |
| 11th Feb 2022 5:30 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 1st Feb 2022 5:00 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 24th Jan 2022 3:00 pm |
RNS |
Appointment of Senior Independent Director |
| 18th Jan 2022 1:00 pm |
RNS |
Holding(s) in Company |
| 13th Jan 2022 7:00 am |
RNS |
Fastest human genome sequence uses Oxford Nanopore |
| 11th Jan 2022 6:00 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 7th Jan 2022 12:00 pm |
RNS |
Update to FY21 revenue guidance |
| 7th Jan 2022 7:00 am |
RNS |
Company to present at JP Morgan Healthcare conf |
| 4th Jan 2022 6:30 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 20th Dec 2021 5:00 pm |
RNS |
Holding(s) in Company |
| 13th Dec 2021 6:15 pm |
RNS |
Share Incentive Plan - Director/PDMR Shareholding |
| 2nd Dec 2021 7:00 am |
RNS |
Oxford Nanopore announces technology updates |
| 1st Dec 2021 7:00 am |
RNS |
Issue of Equity and Total Voting Rights |
| 9th Nov 2021 7:03 am |
RNS |
Update to revenue guidance |
| 3rd Nov 2021 6:00 pm |
RNS |
Holding(s) in Company |
| 1st Nov 2021 6:30 pm |
RNS |
PDMR Notification (ESPP) and Director Declaration |
| 1st Nov 2021 7:00 am |
RNS |
Issue of Equity and Total Voting Rights |
| 14th Oct 2021 5:33 pm |
RNS |
Upgrade to full-year revenue guidance |
